← Back to Search
NLP-Based Feedback for Prostate Cancer (NLP RCT Trial)
Los Angeles, CA
N/A
Waitlist Available
Research Sponsored by Cedars-Sinai Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-9 months (post study analysis)
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to see if using a system that combines natural language processing and artificial intelligence can improve the way doctors communicate risks and benefits to prostate cancer patients during consultations. Patients and doctors will either receive standard
See full description
Who is the study for?
This trial is for men newly diagnosed with localized prostate cancer. Participants will be under the care of one of the 22 physicians involved in the study. The main goal is to improve how doctors and patients talk about treatment risks and benefits, helping patients make better decisions.
What is being tested?
The trial tests a new system that uses NLP+AI to give feedback on doctor-patient conversations about prostate cancer treatments. It compares standard consultations with ones enhanced by AI feedback, aiming to see if this improves decision-making and communication.See study design
What are the potential side effects?
Since this intervention involves communication feedback rather than medical treatment, traditional physical side effects are not applicable. However, there may be psychological impacts related to understanding risk information or decisional conflict.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6-9 months (post study analysis)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-9 months (post study analysis)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Appropriateness of treatment choice
Decisional conflict
Quality of risk communication
+1 moreSecondary study objectives
Improvement of risk communication
Risk Perception and Patient Satisfaction
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: NLP-Based Feedback ArmExperimental Treatment1 Intervention
Group II: Standard of Care ArmActive Control1 Intervention
patients will receive standard of care treatment consultations along with AUA-endorsed educational materials on treatment risks and benefits (for patients) and on SDM (for physicians)
Find a Location
Closest Location:Cedars Sinai Medical Center· Los Angeles, CA· 1976 miles
Who is running the clinical trial?
Cedars-Sinai Medical CenterLead Sponsor
520 Previous Clinical Trials
164,400 Total Patients Enrolled
National Cancer Institute (NCI)NIH
14,057 Previous Clinical Trials
41,149,209 Total Patients Enrolled